Cytopathology
Lung cancers metabolise differently
Researchers have discovered that the two most common forms of lung cancer metabolise nutrients differently, revealing new vulnerabilities that could be exploited in future treatment for patients.
Biomarker for bladder cancer
A new diagnostic technique has revealed a protein biomarker that accurately differentiates bladder cancer from benign inflammation.
A cellular intranet
Professor Mark Evans explains his research into cellular networks that can be rapidly dismantled, reconfigured and rebuilt.
